MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2019 International Congress

    Urodynamic study to distinguish multiple system atrophy from Parkinson’s disease

    KW. Park, JH. Shin, NR. Choi, SY. Jo, MS. Choo, SJ. Chung (Seoul, Republic of Korea)

    Objective: To evaluate differences in urodynamic findings between multiple system atrophy (MSA) and Parkinson’s disease (PD) and identify the utility of urodynamic parameters for the…
  • 2019 International Congress

    Epidemiological study of multiple system atrophy: data from HoRC-MSA Project 2014-2019

    M. Matsushima, I. Yabe, K. Sakushima, I. Iwata, Y. Kanatani, N. Nishimoto, T. Matsuoka, T. Katayama, H. Uesugi, K. Sako, A. Takei, A. Tamakoshi, S. Shimohama, N. Sato, S. Kikuchi, H. Sasaki (Sapporo, Japan)

    Objective: To investigate epidemiological aspects of multiple system atrophy (MSA) in Hokkaido, Japan from the data of the Hokkaido Rare-disease Consortium for MSA (HoRC-MSA). Background:…
  • 2019 International Congress

    Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson’s Disease

    E. Fiorenzato, A. Antonini, V. Camparini, L. Weis, C. Semenza, R. Biundo (Venice, Italy)

    Objective: This study investigated neuropsychological tests most sensitive in differentiating progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) and multiple system atrophy (MSA), and in…
  • 2019 International Congress

    Quantitative evaluation of gait ataxia of Multiple System Atrophy patients

    C. Sato, S. Shirai, M. Matsushima, I. Yabe, H. Sasaki (Sapporo, Japan)

    Objective: To perform gait analysis on patients with multiple system atrophy (MSA) and assess whether the obtained data could be used as neurophysiological biomarkers. Background:…
  • 2019 International Congress

    Measuring disease progression with neuroimaging in MSA-a systematic review

    B. Heim, F. Krismer, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To assess longitudinal changes of serial neuroimaging-derived parameters in MSA. Background: Different neuroimaging modalities hold potential as surrogate markers of neurodegeneration in multiple system…
  • 2019 International Congress

    The severity of motor dysfunctions and autonomic dysfunctions are not correlated in multiple system atrophy

    T. Yamamoto, Y. Yamanaka, A. Sugiyama, S. Hirano, T. Uchiyama, M. Asahina, R. Sakakibara, S. Kuwabara (Chiba, Japan)

    Objective: Although it is well known that patients with multiple system atrophy (MSA) cerebellar dominant type (MSA-C) show severe autonomic dysfunction, the relationship between autonomic…
  • 2019 International Congress

    Multiple System Atrophy – perspectives in diagnosis?

    P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

    Objective: The aim of this study was to study the role of perfusion single photon emission computed tomography (SPECT) in the examination of multiple system…
  • 2019 International Congress

    Three-year follow-up of a patient with a rare combination of taupathy (PSP) and synucleopathy (MSA)

    D. Aygun (Samsun, Turkey)

    Objective: We couldn't find an article showing that MSA and PSP appeared simultaneously in the same patient in the english literature. We wanted to present…
  • 2019 International Congress

    To compare early / late onset MSA from the PAN American MSA (PANMSA) database

    M. Cesarini, E. Gatto, J. Etcheverry, G. da Prat, F. Peralta (Caba, Argentina)

    Objective: Compare two different cohorts of patients with the same pathology differentiated by age of onset. Background: Multiple system atrophy (MSA) is a rare neurodegenerative…
  • 2019 International Congress

    Multiple System Atrophy: phenotypic spectrum approach coupled with brain FDG PET

    A. Eusebio, E. Guedj, JP. Azulay, M. Renaud, M. Boucekine, S. Grimaldi (Marseille, France)

    Objective: This study attempts to identify different phenotypes of patients with MSA and to describe corresponding brain 18-FDG Positron Emission Tomography (PET) patterns. Background: In…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley